Pharma-backed fund to develop new anti-infectives
BRIGHTON: Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development
BRIGHTON: Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development
FEATURED
Drug company deal delivers hope for dementia patients
Proactive alliances among stakeholders can lead to assisted living departments
Investors offering to buy homes from the elderly
Apartment complex to boost housing ahead of mega medical precinct
Derelict building set to be transformed into state-of-the-art medical facility
Idyllic caravan park that’s a grey nomad’s dream revealed
INNOVATION
